No results, please enter a search term above
Twelve human West Nile Virus (WNV) cases have been identified in Philadelphia during the 2022 season. Eight adult residents developed neuroinvasive disease and four developed febrile illness. Eleven cases were hospitalized and one neuroinvasive case was fatal. A presumptive viremic blood donor was also identified, but did not develop symptoms. Positive mosquito pools continue to be identified across the City. The WNV pool positivity in 2022 is higher than the year-to-date historic median rate (43% vs 7%), and higher than rates observed in 2010, 2018 and 2021 (24-39%), peak WNV activity seasons in Philadelphia. Increased risk for human infection will continue in Philadelphia until the first hard frost occurs.
From May through October, the Philadelphia Department of Public Health (PDPH), in collaboration with the PA Department of Environmental Protection, conducts mosquito management activities throughout Philadelphia, which entails surveillance and identification of mosquito pools, testing pools for WNV, and control activities (eliminating breeding sites, larviciding catch basins, ground spraying, etc.). Since May 2022, 49 locations in Philadelphia have been treated to control adult mosquito populations.
Click here to download the latest weekly report of West Nile Virus in a printable format.
Click here to download the 2021 season summary report of West Nile Virus in a printable format.
Week 40 (10/2-10/8) |
2022 Season (5/1 - 10/8) |
|
---|---|---|
Mosquito Pools Tested* |
0 |
893 |
WNV Positive Pools |
0 |
388 |
Humans Tested** |
0 |
23 |
Human WNV Cases |
0 |
12 |
Neuroinvasive WNV |
0 |
8 |
WNV Fever |
0 |
4 |
Human WNV Deaths |
0 |
1 |
Presumptive Viremic Donors |
0 |
1 |
*893 mosquito pools at 179 different mosquito trapping sites
**Testing among case reports received by PDPH only
Advise your patients to:
WNV Testing and Reporting Requirements for Human Surveillance in Philadelphia: